(VIANEWS) – Heartland Express (HTLD), Granite Construction Incorporated (GVA), Eli Lilly and Company (LLY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Heartland Express (HTLD)
68.6% sales growth and 16.88% return on equity
Heartland Express, Inc., together with its subsidiaries, operates as a short-to-medium haul truckload carrier in the United States and Canada. It primarily provides nationwide asset-based dry van truckload service for shippers from Washington to Florida and New England to California; and temperature-controlled truckload services. The company offers its services under Heartland Express and Millis Transfer brand names. It provides traffic appliances, automotive parts, consumer products, paper products, packaged foodstuffs, and retail goods. The company principally serves retailers and manufacturers. Heartland Express, Inc. was founded in 1978 and is headquartered in North Liberty, Iowa.
Earnings Per Share
As for profitability, Heartland Express has a trailing twelve months EPS of $1.69.
PE Ratio
Heartland Express has a trailing twelve months price to earnings ratio of 9.73. Meaning, the purchaser of the share is investing $9.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.88%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 139.6%, now sitting on 968M for the twelve trailing months.
Volume
Today’s last reported volume for Heartland Express is 149549 which is 40.35% below its average volume of 250711.
Yearly Top and Bottom Value
Heartland Express’s stock is valued at $16.44 at 05:22 EST, under its 52-week high of $18.17 and way above its 52-week low of $12.78.
Sales Growth
Heartland Express’s sales growth is 108.9% for the ongoing quarter and 68.6% for the next.
2. Granite Construction Incorporated (GVA)
21.4% sales growth and 4.47% return on equity
Granite Construction Incorporated operates as an infrastructure contractor and a construction materials producer in the United States. It operates through two segments, Construction and Materials segments. The Construction segment engages in the construction and rehabilitation of roads, pavement preservation, bridges, rail lines, airports, marine ports, dams, reservoirs, aqueducts, infrastructure, and site development for use by the public. It also focuses on water-related construction for municipal agencies, commercial water suppliers, industrial facilities, and energy companies. The company also constructs various complex projects, including infrastructure/site development, mining, public safety, tunnel, solar, and power projects. The Materials segment is involved in the production of aggregates and asphalt for internal use, as well as for sale to third parties. In addition, it offers site preparation, mining, and infrastructure services for residential development, energy development, commercial and industrial sites, and other facilities; and provides construction management professional services. The company serves federal agencies, state departments of transportation, local transit authorities, county and city public works departments, school districts and developers, utilities, contractors, landscapers, manufacturers of products requiring aggregate materials, retailers, homeowners, farmers, brokers, and private owners of industrial, commercial, and residential sites. Granite Construction Incorporated was founded in 1922 and is headquartered in Watsonville, California.
Earnings Per Share
As for profitability, Granite Construction Incorporated has a trailing twelve months EPS of $-3.18.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.47%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 4.9%, now sitting on 2.83B for the twelve trailing months.
3. Eli Lilly and Company (LLY)
12.3% sales growth and 64.64% return on equity
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Earnings Per Share
As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $6.68.
PE Ratio
Eli Lilly and Company has a trailing twelve months price to earnings ratio of 47.07. Meaning, the purchaser of the share is investing $47.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 64.64%.
4. AdaptHealth Corp. (AHCO)
9.8% sales growth and 4.73% return on equity
AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
Earnings Per Share
As for profitability, AdaptHealth Corp. has a trailing twelve months EPS of $0.65.
PE Ratio
AdaptHealth Corp. has a trailing twelve months price to earnings ratio of 31.72. Meaning, the purchaser of the share is investing $31.72 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.73%.
5. Medallion Financial Corp. (MFIN)
6.9% sales growth and 18.42% return on equity
Medallion Financial Corp., together with its subsidiaries, operates as a finance company in the United States. It originates, acquires, and services loans that finance taxi medallions and various types of commercial businesses. The company offers consumer loans for the purchase of recreational vehicles, boats, motorcycles, and trailers, as well as to finance home improvements; commercial loans for the purchase of equipment and related assets necessary to open a new business, or purchase or improvement of an existing business; and medallion loans. It also provides debt, mezzanine, and equity investment capital to companies in various industries. In addition, the company raises deposits and conducts other banking activities. Medallion Financial Corp. was founded in 1995 and is headquartered in New York City, New York.
Earnings Per Share
As for profitability, Medallion Financial Corp. has a trailing twelve months EPS of $-0.52.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.42%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 206.83M for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Aug 11, 2022, the estimated forward annual dividend rate is 0.32 and the estimated forward annual dividend yield is 4.43%.
Previous days news about Medallion Financial Corp.(MFIN)
- According to Zacks on Tuesday, 28 February, "Medallion Financial Corp. price-consensus-chart | Medallion Financial Corp. Quote"
6. Pacific Premier Bancorp (PPBI)
5.8% sales growth and 9.98% return on equity
Pacific Premier Bancorp, Inc. operates as the bank holding company for Pacific Premier Bank that provides banking services to businesses, professionals, real estate investors, and non-profit organizations. The company accepts deposit products, such as checking, money market, and savings accounts; and certificates of deposit. Its loan portfolio includes commercial real estate owner and non-owner-occupied, multifamily, construction and land, franchise real estate secured, small business administration (SBA), and SBA paycheck protection program loans; revolving lines or credit, term loans, seasonal loans, and loans secured by liquid collateral; one-to-four family and home equity lines of credit loans; and savings account secured loans and auto loans. The company also offers cash management, electronic banking, treasury management, and online bill payment services. It operates 61 full-service depository branches located in Arizona, California, Nevada, Oregon, and Washington. Pacific Premier Bancorp, Inc. was founded in 1983 and is headquartered in Irvine, California.
Earnings Per Share
As for profitability, Pacific Premier Bancorp has a trailing twelve months EPS of $1.15.
PE Ratio
Pacific Premier Bancorp has a trailing twelve months price to earnings ratio of 28.07. Meaning, the purchaser of the share is investing $28.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.98%.
Volume
Today’s last reported volume for Pacific Premier Bancorp is 307104 which is 29.85% below its average volume of 437842.
Yearly Top and Bottom Value
Pacific Premier Bancorp’s stock is valued at $32.42 at 05:22 EST, way under its 52-week high of $38.51 and way higher than its 52-week low of $27.92.
